Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease

Background. Corticosteroids are often used for the treatment of glomerular diseases. We examined whether bisphosphonate or vitamin D3 has beneficial effects on bone mineral density (BMD) in patients with glomerular diseases being treated with high-dose corticosteroids, including pulse therapy. Metho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2007-06, Vol.22 (6), p.1593-1600
Hauptverfasser:	Kikuchi, Yuichi, Imakiire, Toshihiko, Yamada, Muneharu, Saigusa, Takamitsu, Hyodo, Toshitake, Kushiyama, Taketoshi, Higashi, Keishi, Hyodo, Naomi, Yamamoto, Kojiro, Suzuki, Shigenobu, Miura, Soichiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged bisphosphonate Bone Density Conservation Agents - pharmacology Bone Diseases, Metabolic - chemically induced Bone Diseases, Metabolic - drug therapy Bone Diseases, Metabolic - pathology bone mineral density corticosteroid Dose-Response Relationship, Drug Etidronic Acid - analogs & derivatives Etidronic Acid - pharmacology Female Glomerulonephritis - drug therapy Glomerulonephritis - pathology Humans kidney disease Male Middle Aged Prednisolone - adverse effects Prednisolone - pharmacology Prospective Studies Risedronate Sodium vitamin D
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!